Mohamed El-tanani

发表

DJ-1 Could Predict Worse Prognosis in Esophageal Squamous Cell Carcinoma

T. Mak, K. Chan, G. Srivastava, 2008, Cancer Epidemiology Biomarkers & Prevention.

The regulation and role of osteopontin in malignant transformation and cancer.

F. Campbell, P. Rudland, M. El-Tanani, 2006, Cytokine & growth factor reviews.

Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

J. Winstanley, P. Rudland, R. Barraclough, 2002, Cancer research.

Identification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cells

P. Johnston, P. Rudland, M. El-Tanani, 2009, BMC Research Notes.

BRCA1 Suppresses Osteopontin-mediated Breast Cancer*

P. Pharoah, F. Campbell, P. Rudland, 2006, Journal of Biological Chemistry.

Role of osteopontin in cellular signaling and metastatic phenotype.

M. El-Tanani, Mohamed El-tanani, 2008, Frontiers in bioscience : a journal and virtual library.

Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail‐induced epithelial–mesenchymal transition

P. Johnston, D. Fennell, K. Chan, 2011, The Journal of pathology.

Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer

Ran Wei, H. Kwok, M. El-Tanani, 2017, International journal of biological sciences.

RanGTPase: a candidate for Myc-mediated cancer progression.

P. Johnston, K. O'Byrne, Shu-Dong Zhang, 2013, Journal of the National Cancer Institute.

RanGTPase is transcriptionally regulated by Myc and is required for Myc-mediated cancer progression

K. O'Byrne, Shu-Dong Zhang, D. Fennell, 2012 .

Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells

James T. Murray, Takehiko Sasazuki, Olga Abramczyk, 2012, Bioscience reports.